This Common Pain Med Could Be Raising Dementia Risk

Chronic pain can be a weakening experience. A common drug used to manage the situation can come with its serious dangers. Recent research finds a contact between the drug Gabapentin and a problem between the risk of dementia.

Case Western Reserve University scientists conducted a study investigating the medical records of people with chronic low back pain. People who return Gabapentin were more likely to develop a timely demonstration compared to users than users. The results are called the researchers who need to be more aware of doctors more than this potential complication.

“Our findings are a combination of unity in 10 years between the prescription and cognitive impairment of the temptation between the prescription and cognitive and cognitive impairment of 10 years. published Last week, the regional anesthesia and pain medicine magazine.

Blackbird It is an anti-nerve pain and anti-rested leg syndrome. And sometimes used to treat chronic low back pain, especially if nerves are involved. First of all, it works by reducing the abnormal electrical activity of the neurons of the brain.

As useful as Gabapentin can be, somewhat-Ever smooth-Reaearch offered a possible connection to the dementia and cognitive disorder. To better understand this potential risk, researchers have investigated the use of chronic low lower back pain with patients. Between 2004 and 2024, more than 26,000 patients analyzed, or have been or whether they were or have compared similar groups of patients whether similar patients were or not gabapent.

People who are assigned to gabapent six or more times, the probability of diagnosis of dementia (about 30% more likely, more likely) and moderate cognitive violations (85% more than 85%), found researchers. This increase in the unusual risks was higher than in people under 65 years of age, as well as 12 or more recipes (compared to people who receive less recipes).

These types of retrospective studies can show a connection between only two things, clear a clear result and effect connection. However, the findings should be investigated after this to understand whether this link is original and the exact mechanisms of those behind them and determine the exact mechanisms of the standers behind it. Now doctors, at least, taking the cognitive health of patients, they must be at least more careful not to be more active in following cognitive health.

“Our results support Gabapentin in adult patients who define Gabapentin to evaluate the potential cognitive decline,” said business researchers.